Skip to content

Vivani Medical VANI Neurostimulation Division — D&A

Other segment segments

Biopharm Division
$130K+31.3%

Similar metrics at other companies

Asset Entities logo
ASSTMedical Device — D&A
$32K
Harmony Biosciences Holdings, Inc. logo
HRMYRare Neurological Diseases — D&A
$5.97M0.0%
OSI Systems logo
OSISOptoelectronics And Manufacturing Division — D&A
$1.79M+9.9%
OSI Systems logo
OSISHealthcare Division — D&A
$1.04M-18.0%
OSI Systems logo
OSISSecurity Division — D&A
$6.22M-14.4%
Ivanhoe Electric logo
IEEnergy Storage — D&A
$0-100%

Other financials

Income statement

See full
Revenue-
Gross profit$130.0K
Operating income-$6.8M-4.0%
Net income-$6.8M-7.6%
EPS (diluted)-$0.08+27.3%

Balance sheet

See full
Cash & equivalents$19.0M+57.7%
Total debt$18.3M-3.5%
Total equity$19.1M+64.2%
Total assets$42.4M+19.5%

Cash flow

See full
Operating cash flow-$6.2M-20.0%
CapEx$3.0K-40.0%
Free cash flow-$6.2M-19.9%

Valuation

See full
Market cap$106.93M+40.0%
Enterprise value$106.17M+19.3%

Profitability

See full
Gross margin36.3%
Operating margin-1,004.9%
Net margin-994.1%
FCF margin-832.3%

Returns & leverage

See full
Return on equity-176.4%+175pp
Debt / equity-0.7×
Current ratio3.2×+0.8×

Where this comes from

Reported directly by Vivani Medical in its filing.

Tagged under the XBRL concept us-gaap:DepreciationAndAmortization.

The official record: Vivani Medical’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vivani Medical's neurostimulation division — d&a.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vivani Medical's neurostimulation division — D&A?
Vivani Medical (VANI) reported neurostimulation division — D&A of $3.25K in Q4 2025.
How has Vivani Medical's neurostimulation division — D&A changed year-over-year?
Vivani Medical's neurostimulation division — D&A decreased by 56.7% year-over-year, from $7.5K to $3.25K.
What is the long-term trend for Vivani Medical's neurostimulation division — D&A?
Over 2 years (2023 to 2025), Vivani Medical's neurostimulation division — D&A has grown at a -45.6% compound annual growth rate (CAGR), from $44K to $13K.
What does neurostimulation division — D&A mean?
Represents the non-cash allocation of the cost of tangible and intangible assets over their useful lives within the neurostimulation division. This metric reflects the wear and tear or obsolescence of the segment's capital equipment and technology portfolio. It is essential for understanding the true economic cost of maintaining the division's asset base.